chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Fatigue, Head discomfort, Headache, Magnetic resonance imaging
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nausea, Paraesthesia, Pyrexia, SARS-CoV-2 test, Vision blurred
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.
Age: 25.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness; Unsteadiness; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 25-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0171), dose 1 via an unspecified route of administration, administered in Arm Right on 02May2021 12:00 (Age at vaccination: 25) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy. The patient's concomitant medications were not reported. The patient previously took erythromycin and sulfa. On 02May2021 12:00, the patient experienced Immediate reaction of arms tingling; Nausea; Vomiting; Headache; Fever; Fatigue; Shortness of breath; Head pressure; Double vision; Cannot concentrate for any length of time; Dizziness and Unsteadiness . Patient was received steroids as treatment for events. No hospitalization prolonged. The patient underwent lab tests and procedures which included blood test: normal on, electrocardiogram: normal on, magnetic resonance imaging: normal on, sars-cov-2 test: negative on 06May2021, sars-cov-2 test: negative on 19May2021. It was reported that patient had basic vaccine symptoms the first week including headache, nausea, fever. After a week, COVID fog/fatigue symptoms began. It is currently 6 weeks later and patient had fatigue, shortness of breath, head pressure, double vision, cannot concentrate for any length of time and dizziness/unsteadiness. I have not been able to go to work since the vaccine and have people helping take care of me. I cannot take a shower without being short of breath. I have been put on 2 different rounds of steroids - the 2nd more aggressive, which did not make a difference. I have been to my general doctor several times, an allergist and a neurologist. I had no previous health problems. Symptoms had not improved in the past 3-4 weeks. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has been not tested for COVID-19. The clinical outcome of all events were not recovered.  Follow-up attempts are needed. Further information is requested.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Borrelia test, Hypoaesthesia, Magnetic resonance imaging, Myelitis transverse
Clinical narrative: negative contrast and non contrast brain MRI; Vertigo; left facial numbness/left arm numbness; intermittent headaches; stiffness in both thumbs, progressed to right arm; paresthesias in feet; This is a spontaneous report from a contactable other health care professional (HCP) (patient). A 37-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration at the age of 37-year-old administered in arm left on 08Jan2021 11:00 at single dose for covid-19 immunisation. Medical history included essential tremor. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Concomitant medications included multi vitamin; propranolol; paracetamol (TYLENOL); ibuprofen (MOTRIN); naproxen sodium (ALEVE), all received within 2 weeks of vaccination. The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730) on 20Dec2020 09:00 AM at arm left for COVID-19 immunisation. On 08Apr2021 20:00, The patient experienced 4/8 Vertigo, 4/9 left facial numbness, 5/5 left facial numbness and left arm numbness became persistent, intermittent headaches, 5/11 stiffness in both thumbs, progressed to right arm and 6/2 paresthesias in feet. Did not respond to NSAIDS or course of prednisone. 6/3 negative contrast and non contrast brain MRI. The adverse event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered in Hospital. Since the vaccination, the patient hasn't been tested for COVID-19. The patient underwent lab tests included laboratory test: unknown results on unspecified date, brain MRI: negative on 08Apr2021. The patient received the treatment (Labs, brain MRI) for adverse events. The outcome of events was not recovered.; Sender's Comments: The reported event Magnetic resonance imaging head abnormal is likely an intercurrent condition and not related to BNT162B2 .
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypoaesthesia, Laboratory test, Magnetic resonance imaging head, Magnetic resonance imaging head abnormal
Clinical narrative: negative contrast and non contrast brain MRI; Vertigo; left facial numbness/left arm numbness; intermittent headaches; stiffness in both thumbs, progressed to right arm; paresthesias in feet; This is a spontaneous report from a contactable other health care professional (HCP) (patient). A 37-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration at the age of 37-year-old administered in arm left on 08Jan2021 11:00 at single dose for covid-19 immunisation. Medical history included essential tremor. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Concomitant medications included multi vitamin; propranolol; paracetamol (TYLENOL); ibuprofen (MOTRIN); naproxen sodium (ALEVE), all received within 2 weeks of vaccination. The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730) on 20Dec2020 09:00 AM at arm left for COVID-19 immunisation. On 08Apr2021 20:00, The patient experienced 4/8 Vertigo, 4/9 left facial numbness, 5/5 left facial numbness and left arm numbness became persistent, intermittent headaches, 5/11 stiffness in both thumbs, progressed to right arm and 6/2 paresthesias in feet. Did not respond to NSAIDS or course of prednisone. 6/3 negative contrast and non contrast brain MRI. The adverse event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered in Hospital. Since the vaccination, the patient hasn't been tested for COVID-19. The patient underwent lab tests included laboratory test: unknown results on unspecified date, brain MRI: negative on 08Apr2021. The patient received the treatment (Labs, brain MRI) for adverse events. The outcome of events was not recovered.; Sender's Comments: The reported event Magnetic resonance imaging head abnormal is likely an intercurrent condition and not related to BNT162B2 .
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Paraesthesia, Vertigo
Clinical narrative: negative contrast and non contrast brain MRI; Vertigo; left facial numbness/left arm numbness; intermittent headaches; stiffness in both thumbs, progressed to right arm; paresthesias in feet; This is a spontaneous report from a contactable other health care professional (HCP) (patient). A 37-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EK5730), via an unspecified route of administration at the age of 37-year-old administered in arm left on 08Jan2021 11:00 at single dose for covid-19 immunisation. Medical history included essential tremor. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Concomitant medications included multi vitamin; propranolol; paracetamol (TYLENOL); ibuprofen (MOTRIN); naproxen sodium (ALEVE), all received within 2 weeks of vaccination. The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730) on 20Dec2020 09:00 AM at arm left for COVID-19 immunisation. On 08Apr2021 20:00, The patient experienced 4/8 Vertigo, 4/9 left facial numbness, 5/5 left facial numbness and left arm numbness became persistent, intermittent headaches, 5/11 stiffness in both thumbs, progressed to right arm and 6/2 paresthesias in feet. Did not respond to NSAIDS or course of prednisone. 6/3 negative contrast and non contrast brain MRI. The adverse event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered in Hospital. Since the vaccination, the patient hasn't been tested for COVID-19. The patient underwent lab tests included laboratory test: unknown results on unspecified date, brain MRI: negative on 08Apr2021. The patient received the treatment (Labs, brain MRI) for adverse events. The outcome of events was not recovered.; Sender's Comments: The reported event Magnetic resonance imaging head abnormal is likely an intercurrent condition and not related to BNT162B2 .
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Aldolase normal, Angiotensin converting enzyme, Anti-cyclic citrullinated peptide antibody negative, Antineutrophil cytoplasmic antibody negative
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aspartate aminotransferase increased, Asthenia, Blood creatine phosphokinase normal, Blood glucose decreased, Blood heavy metal normal
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood immunoglobulin A, Blood immunoglobulin G normal, Blood immunoglobulin M, Blood thyroid stimulating hormone, C-reactive protein increased
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: CSF oligoclonal band absent, Complement factor C3, Complement factor C4, Dissociation, Electromyogram abnormal
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrophoresis protein, Epstein-Barr virus antibody negative, Facetectomy, Foraminotomy, Gastrointestinal pathogen panel
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Glycosylated haemoglobin, Guillain-Barre syndrome, HIV test negative, Hepatitis viral test negative, IL-2 receptor assay
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Inflammation, Light chain analysis normal, Lumbar puncture, Magnetic resonance imaging spinal abnormal, Motor neurone disease
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Nerve conduction studies abnormal, Neurological examination, Protein total increased, Red blood cell count decreased
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Red blood cell sedimentation rate increased, Rheumatoid factor negative, Spinal laminectomy, Spinal osteoarthritis, Treponema test negative
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urine electrophoresis, Vertebral foraminal stenosis, Viral test negative, Vitamin B6 normal, White blood cell count decreased
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood glucose normal, CSF protein increased, CSF red blood cell count, CSF white blood cell count
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Central nervous system inflammation, Electromyogram abnormal, Neuralgia, Polyneuropathy
Clinical narrative: Inflamed nerves beginning in upper legs, then going to lower extremities, severe nerve pain, followed by body weKNESS,
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Confusional state, Dizziness, Dry skin, Dyspnoea
Clinical narrative: sick. In and out of the hospital; vertigo; brain fog; shortness of breath; weakness; Headaches; fatigue; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 39-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Ew0162), via an unspecified route of administration, administered in Arm Right on 20Apr2021 10:45 (at age a vaccination: 39-year-old) as single dose for covid-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, allergies to Penicillin, Erythromycin and Brazil nuts. The patient's concomitant medications were not reported. The patient took first dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in Arm Right on 27Mar2021 03:15 PM as single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that on 20Apr2021 12:00 PM, the patient was still sick, In and out of the hospital. Headaches, vertigo, fever, weakness, brain fog, fatigue, shortness of breath. On an unspecified date in 2021, the patient was hospitalized for the events for 3 days. The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 14May2021. The patient stated that "they tested me more than once". Therapeutic measures were taken as a result of events with Steroids, blood thinners, pain meds. The outcome for the events was not resolved.  Follow up information has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Fibrin D dimer, Flushing, Gingival bleeding
Clinical narrative: sick. In and out of the hospital; vertigo; brain fog; shortness of breath; weakness; Headaches; fatigue; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 39-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Ew0162), via an unspecified route of administration, administered in Arm Right on 20Apr2021 10:45 (at age a vaccination: 39-year-old) as single dose for covid-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, allergies to Penicillin, Erythromycin and Brazil nuts. The patient's concomitant medications were not reported. The patient took first dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in Arm Right on 27Mar2021 03:15 PM as single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that on 20Apr2021 12:00 PM, the patient was still sick, In and out of the hospital. Headaches, vertigo, fever, weakness, brain fog, fatigue, shortness of breath. On an unspecified date in 2021, the patient was hospitalized for the events for 3 days. The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 14May2021. The patient stated that "they tested me more than once". Therapeutic measures were taken as a result of events with Steroids, blood thinners, pain meds. The outcome for the events was not resolved.  Follow up information has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Heart rate increased, Hyperhidrosis, Myalgia, Oedema
Clinical narrative: sick. In and out of the hospital; vertigo; brain fog; shortness of breath; weakness; Headaches; fatigue; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 39-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Ew0162), via an unspecified route of administration, administered in Arm Right on 20Apr2021 10:45 (at age a vaccination: 39-year-old) as single dose for covid-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, allergies to Penicillin, Erythromycin and Brazil nuts. The patient's concomitant medications were not reported. The patient took first dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in Arm Right on 27Mar2021 03:15 PM as single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that on 20Apr2021 12:00 PM, the patient was still sick, In and out of the hospital. Headaches, vertigo, fever, weakness, brain fog, fatigue, shortness of breath. On an unspecified date in 2021, the patient was hospitalized for the events for 3 days. The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 14May2021. The patient stated that "they tested me more than once". Therapeutic measures were taken as a result of events with Steroids, blood thinners, pain meds. The outcome for the events was not resolved.  Follow up information has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Rash, Tinnitus, Visual impairment
Clinical narrative: sick. In and out of the hospital; vertigo; brain fog; shortness of breath; weakness; Headaches; fatigue; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 39-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Ew0162), via an unspecified route of administration, administered in Arm Right on 20Apr2021 10:45 (at age a vaccination: 39-year-old) as single dose for covid-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, allergies to Penicillin, Erythromycin and Brazil nuts. The patient's concomitant medications were not reported. The patient took first dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in Arm Right on 27Mar2021 03:15 PM as single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that on 20Apr2021 12:00 PM, the patient was still sick, In and out of the hospital. Headaches, vertigo, fever, weakness, brain fog, fatigue, shortness of breath. On an unspecified date in 2021, the patient was hospitalized for the events for 3 days. The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 14May2021. The patient stated that "they tested me more than once". Therapeutic measures were taken as a result of events with Steroids, blood thinners, pain meds. The outcome for the events was not resolved.  Follow up information has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dyspnoea, Fatigue, Feeling abnormal, Headache
Clinical narrative: sick. In and out of the hospital; vertigo; brain fog; shortness of breath; weakness; Headaches; fatigue; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 39-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Ew0162), via an unspecified route of administration, administered in Arm Right on 20Apr2021 10:45 (at age a vaccination: 39-year-old) as single dose for covid-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, allergies to Penicillin, Erythromycin and Brazil nuts. The patient's concomitant medications were not reported. The patient took first dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in Arm Right on 27Mar2021 03:15 PM as single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that on 20Apr2021 12:00 PM, the patient was still sick, In and out of the hospital. Headaches, vertigo, fever, weakness, brain fog, fatigue, shortness of breath. On an unspecified date in 2021, the patient was hospitalized for the events for 3 days. The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 14May2021. The patient stated that "they tested me more than once". Therapeutic measures were taken as a result of events with Steroids, blood thinners, pain meds. The outcome for the events was not resolved.  Follow up information has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Illness, Pyrexia, SARS-CoV-1 test, Vertigo
Clinical narrative: sick. In and out of the hospital; vertigo; brain fog; shortness of breath; weakness; Headaches; fatigue; fever; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 39-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Ew0162), via an unspecified route of administration, administered in Arm Right on 20Apr2021 10:45 (at age a vaccination: 39-year-old) as single dose for covid-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, allergies to Penicillin, Erythromycin and Brazil nuts. The patient's concomitant medications were not reported. The patient took first dose of bnt162b2 (BNT162B2, PFIZER-BIOECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613) via an unspecified route of administration, administered in Arm Right on 27Mar2021 03:15 PM as single dose for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine or any other medications within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. It was reported that on 20Apr2021 12:00 PM, the patient was still sick, In and out of the hospital. Headaches, vertigo, fever, weakness, brain fog, fatigue, shortness of breath. On an unspecified date in 2021, the patient was hospitalized for the events for 3 days. The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 14May2021. The patient stated that "they tested me more than once". Therapeutic measures were taken as a result of events with Steroids, blood thinners, pain meds. The outcome for the events was not resolved.  Follow up information has been requested.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: DEATH; This spontaneous report received from a health care professional (nurse) concerned a 84 years old white and non Hispanic or Latino male.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, 1 total administered to left arm on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-MAY-2021, the patient died. The patient died due to an unknown cause. It was unknown whether an autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20210642608-Janssen Covid-19 Vaccine Ad26.Cov2.S- Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Appendicitis, Laboratory test
Clinical narrative: Acute appendicitis; This is a spontaneous report from a contactable consumer (patient). A 15-year-old male patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0187, Expiration date not reported), via an unspecified route of administration in Arm Left on 15Jun2021 13:15 as dose 2, single for covid-19 immunisation administered at Doctor's office/urgent care. Medical history and concomitant medications were not reported. No known allergies. Previously the patient received first dose bnt162b2 (Lot number RW0185), in Arm left on 25May2021 13:15 for covid-19 immunization. On 16Jun2021 20:00, the patient experienced acute appendicitis and was admitted in emergency room/department or urgent care and underwent appendectomy as a corrective measure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient not been tested for COVID-19. The outcome of the event was recovering.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Appendicitis
Clinical narrative: Acute appendicitis; This is a spontaneous report from a contactable consumer (patient). A 15-year-old male patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0187, Expiration date not reported), via an unspecified route of administration in Arm Left on 15Jun2021 13:15 as dose 2, single for covid-19 immunisation administered at Doctor's office/urgent care. Medical history and concomitant medications were not reported. No known allergies. Previously the patient received first dose bnt162b2 (Lot number RW0185), in Arm left on 25May2021 13:15 for covid-19 immunization. On 16Jun2021 20:00, the patient experienced acute appendicitis and was admitted in emergency room/department or urgent care and underwent appendectomy as a corrective measure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient not been tested for COVID-19. The outcome of the event was recovering.  Information on Lot/Batch number was available. Additional information has been requested.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ammonia normal, Antibody test negative, Antinuclear antibody positive, Asthenia, Blood folate
Clinical narrative: Per daughter:  feeling tired and week, he went to the ER and was sent home.  He went back due to worseing of weakness and was eventually sent to Pittsburgh hospital for further testing.   His condition escalated to paralysis.  Guillain-Barre syndrome was a possible  diagnosis.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: CSF culture negative, Cerebral infarction, Demyelinating polyneuropathy, Electromyogram abnormal, Endotracheal intubation
Clinical narrative: Per daughter:  feeling tired and week, he went to the ER and was sent home.  He went back due to worseing of weakness and was eventually sent to Pittsburgh hospital for further testing.   His condition escalated to paralysis.  Guillain-Barre syndrome was a possible  diagnosis.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal, Mobility decreased
Clinical narrative: Per daughter:  feeling tired and week, he went to the ER and was sent home.  He went back due to worseing of weakness and was eventually sent to Pittsburgh hospital for further testing.   His condition escalated to paralysis.  Guillain-Barre syndrome was a possible  diagnosis.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Plasmapheresis, Respiratory distress, Rheumatoid factor negative, Treponema test negative
Clinical narrative: Per daughter:  feeling tired and week, he went to the ER and was sent home.  He went back due to worseing of weakness and was eventually sent to Pittsburgh hospital for further testing.   His condition escalated to paralysis.  Guillain-Barre syndrome was a possible  diagnosis.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Viral test negative, Vitamin B1, Vitamin B12 normal, Vitamin B6 normal
Clinical narrative: Per daughter:  feeling tired and week, he went to the ER and was sent home.  He went back due to worseing of weakness and was eventually sent to Pittsburgh hospital for further testing.   His condition escalated to paralysis.  Guillain-Barre syndrome was a possible  diagnosis.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Fatigue, Paralysis
Clinical narrative: Per daughter:  feeling tired and week, he went to the ER and was sent home.  He went back due to worseing of weakness and was eventually sent to Pittsburgh hospital for further testing.   His condition escalated to paralysis.  Guillain-Barre syndrome was a possible  diagnosis.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Ischaemic stroke, Magnetic resonance imaging
Clinical narrative: ISCHAEMIC STROKE; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a 63 year old female of unspecified race and ethnic origin. The patient's weight and height were not reported. The patient was healthy and had no underlying diseases. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-APR-2021, the patient experienced headache and fatigue for the first 24 hours. On 16-JUN-2021, the patient experienced ischaemic stroke and had visited emergency room (ER).The patient was treated with TPA and the stroke symptoms were resolved The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from ischaemic stroke, and the outcome of headache and fatigue was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20210651351, covid-19 vaccine ad26.cov2.s, Ischaemic stroke-This event is considered Un assessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Ischaemic stroke
Clinical narrative: ISCHAEMIC STROKE; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a 63 year old female of unspecified race and ethnic origin. The patient's weight and height were not reported. The patient was healthy and had no underlying diseases. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 06-APR-2021, the patient experienced headache and fatigue for the first 24 hours. On 16-JUN-2021, the patient experienced ischaemic stroke and had visited emergency room (ER).The patient was treated with TPA and the stroke symptoms were resolved The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from ischaemic stroke, and the outcome of headache and fatigue was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20210651351, covid-19 vaccine ad26.cov2.s, Ischaemic stroke-This event is considered Un assessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Injection site pain, Lymphadenopathy, Mammogram, Pain
Clinical narrative: After the 1st shot, I had the usual sore arm and swelling. In the next few days, there was a large amount of swelling on the right side. Pain at the injection site, lymph swelling. It stayed pretty constant and I did my best to move my arm and use ice to combat the pain. For my second shot, I was still experiencing pain on the right side so I asked to have it in the left. I reacted with the typical low-grade fever and aches. I had some slight swelling on the left side but it went away in about 24 hours. Within that week the right side axillary area swelled up and pain got worse. My breast became very swollen too.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pyrexia, Ultrasound breast
Clinical narrative: After the 1st shot, I had the usual sore arm and swelling. In the next few days, there was a large amount of swelling on the right side. Pain at the injection site, lymph swelling. It stayed pretty constant and I did my best to move my arm and use ice to combat the pain. For my second shot, I was still experiencing pain on the right side so I asked to have it in the left. I reacted with the typical low-grade fever and aches. I had some slight swelling on the left side but it went away in about 24 hours. Within that week the right side axillary area swelled up and pain got worse. My breast became very swollen too.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: Fever, fatigue, chills, and nausea
Age: 60.0
Sex: F
Vaccine: UNK
Symptoms: Injection site pain, Myalgia, Pyrexia
Clinical narrative: Muscle pain, aches, low grade fever.  Arm sore at injection site
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: My 2nd vaccine dose reaction in the first week included strong joint pain (every single joint in both hands and wrists, along with knees, hips, and other joints), which was completely new to me.  That had seemed to resolve, however now 7.5 weeks after that 2nd dose, I've realized that I've had most of the day and night joint pain in one, the other, or both my hips for at least 2 weeks now (so from weeks ~5-7.5 after my 2nd vaccine dose), and this has not yet resolved.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: THE NURSE ACCIDENTALLY GAVE 1ST DOSE OF PFIZER VACCINE TO 11 YEAR OLD KID.  PFIZER IS INDICATED FOR 12 YEARS AND UP.  SO FAR, THE PATIENT DOESN'T HAVE ANY SIDE EFFECTS YET.  WE NOTIFIED THE PATIENT'S MOM ABOUT THE INCIDENT AND NOT TO GET 2ND DOSE UNTIL THE PATIENT TURNS 12.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal dreams, Arthralgia, Chest discomfort, Chest pain, Disturbance in attention
Clinical narrative: Extreme fatigue, brain fog, constricted chest, chest pain for 4 days after my second dose. Now, I've been experiencing continued ongoing fatigue for 6 weeks. My legs grow heavy each day. I pass out from exhaustion early each night. I have trouble concentrating. I'm experiencing ankle and wrist pain with a feeling of low circulation as my feet and hands fall asleep if I sit too long. I'm also having vivid nightmares on an ongoing basis. Other than a back injury, I was healthy and normal before this vaccine. I have not been to a doctor. I have been resting, focused on eating well and taking 3000mg of Vit C a day.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Limb discomfort
Clinical narrative: Extreme fatigue, brain fog, constricted chest, chest pain for 4 days after my second dose. Now, I've been experiencing continued ongoing fatigue for 6 weeks. My legs grow heavy each day. I pass out from exhaustion early each night. I have trouble concentrating. I'm experiencing ankle and wrist pain with a feeling of low circulation as my feet and hands fall asleep if I sit too long. I'm also having vivid nightmares on an ongoing basis. Other than a back injury, I was healthy and normal before this vaccine. I have not been to a doctor. I have been resting, focused on eating well and taking 3000mg of Vit C a day.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Influenza like illness
Clinical narrative: Severe flu like reactions for 2.5 days. Fever, extreme fatigue, body muscle aches, chills, headache, loss of appetite, slight nausea.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: Severe flu like reactions for 2.5 days. Fever, extreme fatigue, body muscle aches, chills, headache, loss of appetite, slight nausea.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Atrioventricular block, Death, Dysstasia
Clinical narrative: Feb 8th 2nd vaccination. Next day lost consciousness, fell no injuries. Following day Feb 10th weak and could not stand, BP low, Dr sent him via ambulance. EMS identified him having a heart attack that started Feb 9th. He had no cardiac history He was hospitalized for a sudden blockage, had a vtach episode, did not lose consciousness, one stent placement, had a 2nd vtach episode and did lose consciousness. Placed on blood thinner, within a few days had uncontrolled urinary bleeding, catheter to irrigate, changed blood thinners and did not stop. Continued weakness and decline. Then developed pneumonia the following week. Placed on antibiotics, oxygen 2-7 L/nc. Went to rehab, back and forth to hospital. Came home twice, once Feb 14th for 24 hours, then 2nd time March 9 (his birthday) for his final 2 weeks  t home where I cared for him until he passed March 21st. On 4L/NC, did not have catheter, bleeding had stopped.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Haemorrhage urinary tract, Hypotension, Loss of consciousness, Myocardial infarction
Clinical narrative: Feb 8th 2nd vaccination. Next day lost consciousness, fell no injuries. Following day Feb 10th weak and could not stand, BP low, Dr sent him via ambulance. EMS identified him having a heart attack that started Feb 9th. He had no cardiac history He was hospitalized for a sudden blockage, had a vtach episode, did not lose consciousness, one stent placement, had a 2nd vtach episode and did lose consciousness. Placed on blood thinner, within a few days had uncontrolled urinary bleeding, catheter to irrigate, changed blood thinners and did not stop. Continued weakness and decline. Then developed pneumonia the following week. Placed on antibiotics, oxygen 2-7 L/nc. Went to rehab, back and forth to hospital. Came home twice, once Feb 14th for 24 hours, then 2nd time March 9 (his birthday) for his final 2 weeks  t home where I cared for him until he passed March 21st. On 4L/NC, did not have catheter, bleeding had stopped.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Stent placement, Ventricular tachycardia
Clinical narrative: Feb 8th 2nd vaccination. Next day lost consciousness, fell no injuries. Following day Feb 10th weak and could not stand, BP low, Dr sent him via ambulance. EMS identified him having a heart attack that started Feb 9th. He had no cardiac history He was hospitalized for a sudden blockage, had a vtach episode, did not lose consciousness, one stent placement, had a 2nd vtach episode and did lose consciousness. Placed on blood thinner, within a few days had uncontrolled urinary bleeding, catheter to irrigate, changed blood thinners and did not stop. Continued weakness and decline. Then developed pneumonia the following week. Placed on antibiotics, oxygen 2-7 L/nc. Went to rehab, back and forth to hospital. Came home twice, once Feb 14th for 24 hours, then 2nd time March 9 (his birthday) for his final 2 weeks  t home where I cared for him until he passed March 21st. On 4L/NC, did not have catheter, bleeding had stopped.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: After and elevated heart rate for 15 hours.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Cardiac flutter, Chest X-ray, Dyspnoea, Electrocardiogram
Clinical narrative: All symptoms aligned with the reported Heart Inflammation reactions. Primary symptom showed as  shortness of breath and noticeable heart "flutter"/pounding and heart rate spikes. that began a week or so after the 1st vaccination.  The Emergency room was visited soon after these symptoms began but tests came back inconclusive. Symptoms gradually improved over 1-2 weeks but returned more significantly after the 2nd vaccination shot. These symptoms lasted for about a month.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: All symptoms aligned with the reported Heart Inflammation reactions. Primary symptom showed as  shortness of breath and noticeable heart "flutter"/pounding and heart rate spikes. that began a week or so after the 1st vaccination.  The Emergency room was visited soon after these symptoms began but tests came back inconclusive. Symptoms gradually improved over 1-2 weeks but returned more significantly after the 2nd vaccination shot. These symptoms lasted for about a month.